Influenza, Prevention Starts with Children: Pediatric Vaccines at a 'Slow Pace' Compared to Adult Ones - JIJI PRESSInfluenza, Prevention Starts with Children: Pediatric Vaccines at a 'Slow Pace' Compared to Adult Ones
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.10 Articles
10 Articles
(Adnkronos) "Every year children are among the most affected by the flu, but also among the least protected: the vaccine covers in the paediatric age remain still much lower than those recorded in adults." To identify shared strategies to increase the coverage of institutions, federations and health professionals have participated in Rome today at the [...]
canaledieci.it
Children are among the most affected by the flu every year, but also among the least protected: the vaccine covers in the paediatric age are still much lower than those recorded in adults. To identify shared strategies to increase the coverage of institutions, federations and health professionals have participated in Rome today at the [...]
Rec News | Lontani dal mainstream
notizie.itChildren are among the most affected by influenza every year, but also among the least protected: the vaccine covers in the paediatric age are still much lower than those recorded in adults. To identify shared strategies to increase the coverage of institutions, federations and health professionals have participated in Rome today at the event [...] The article Influence, prevention starts from children: pediatric vaccines at a slow pace compared…
Il Quotidiano del Sud
Il Quotidiano del Sud Paediatric flu shot, the prevention summit in Rome Rome, Sept. 29 (askanews) - Increase vaccination coverage for children to protect children and reduce pressure on health services. This is the objective of the conference “Flu vaccination - Prevention starts from childhood”, organized in Rome by NOMOS Center for Parliamentary Studies with the non-conditioning contribution of AstraZeneca. Among the central issues addressed d…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
